<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Vigabatrin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Vigabatrin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Vigabatrin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Vigabatrin</b>, brand name <b>Sabril</b>, is a medication used to treat epilepsy. It became available as a generic medication in 2019.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Vigabatrin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Vigabatrin2DCSD.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Vigabatrin2DCSD.svg.png" data-file-width="819" data-file-height="419" data-file-type="drawing" height="113" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Vigabatrin_ball-and-stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Vigabatrin_ball-and-stick.png" data-file-width="2000" data-file-height="1440" data-file-type="bitmap" height="158" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Sabril</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>γ-Vinyl-GABA</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/cdi/vigabatrin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cdi/vigabatrin.html'" tppabs="https://www.drugs.com/cdi/vigabatrin.html" class="external text external">Consumer Drug Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a610016.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a610016.html'" tppabs="https://medlineplus.gov/druginfo/meds/a610016.html" class="external text external">a610016</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Oral</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N03AG04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N03AG04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N03AG04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N03AG04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>80–90%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>0%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>not metabolized</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>5–8 hours in young adults, 12–13 hours in the elderly.</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-4-aminohex-5-enoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60643-86-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60643-86-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=60643-86-9" class="external text external">60643-86-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5665  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5665'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5665" class="external text external">5665</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4821  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4821'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4821" class="external text external">4821</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01080'" tppabs="https://www.drugbank.ca/drugs/DB01080" class="external text external">DB01080</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5463.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5463.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5463.html" class="external text external">5463</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=GR120KRT6K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=GR120KRT6K'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=GR120KRT6K" class="external text external">GR120KRT6K</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00535'" tppabs="https://www.kegg.jp/entry/D00535" class="external text external">D00535</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL89598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL89598'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL89598" class="external text external">ChEMBL89598</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID4041153  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID4041153'" tppabs="https://comptox.epa.gov/dashboard/DTXSID4041153" class="external text external">DTXSID4041153</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.165.122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.165.122'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.165.122" class="external text external">100.165.122</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>6</sub><span>H</span><sub>11</sub><span>N</span><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">129.159</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CCC%28%5CC%3DC%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CCC%28%5CC%3DC%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29CCC%28%5CC%3DC%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>171 to 177<span>&nbsp;</span>°C (340 to 351<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)CCC(\C=C)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:PJDFLNIOAUIZSL-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470630102&page2=Vigabatrin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470630102&page2=Vigabatrin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470630102&page2=Vigabatrin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>It works by inhibiting the breakdown of <a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">γ-aminobutyric acid</a> (GABA). It is also known as <b>γ-vinyl-GABA</b>, and is a structural analogue of GABA, but does not bind to GABA receptors.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-0"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Epilepsy">Epilepsy</h3></summary>
    
<p>In Canada, vigabatrin is approved for use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-1"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>As of 2003, vigabatrin is approved in Mexico for the treatment of epilepsy that is not satisfactorily controlled by conventional therapy (adjunctive or monotherapy) or in recently diagnosed patients who have not tried other agents (monotherapy).<span class="mw-ref" id="cite_ref-mexicanuses_3-0"><a href="#cite_note-mexicanuses-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Vigabatrin is also indicated for monotherapy use in secondarily generalized tonic-clonic seizures, partial seizures, and in infantile spasms due to West syndrome.<span class="mw-ref" id="cite_ref-mexicanuses_3-1"><a href="#cite_note-mexicanuses-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>On August 21, 2009, Lundbeck announced that the U.S. Food and Drug Administration had granted two New Drug Application approvals for vigabatrin. The drug is indicated as monotherapy for pediatric patients one month to two years of age with infantile spasms for whom  the potential benefits outweigh the potential risk of vision loss, and as adjunctive (add-on) therapy for adult patients with refractory complex partial seizures (CPS) who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss.</p>

<p>In 1994, Feucht and Brantner-Inthaler reported that vigabatrin reduced seizures by 50-100% in 85% of children with Lennox-Gastaut syndrome who had poor results with <a href="Sodium_valproate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_valproate" title="Sodium valproate" class="mw-redirect">sodium valproate</a>.<span class="mw-ref" id="cite_ref-lennoxgastaut_4-0"><a href="#cite_note-lennoxgastaut-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Others">Others</h3></summary>
    
<p>Vigabatrin reduced cholecystokinin tetrapeptide-induced symptoms of panic disorder, in addition to elevated <a href="Cortisol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cortisol" title="Cortisol">cortisol</a> and ACTH levels, in healthy volunteers.<span class="mw-ref" id="cite_ref-vigabatrinpanic_5-0"><a href="#cite_note-vigabatrinpanic-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>Vigabatrin is also used to treat seizures in succinic semialdehyde dehydrogenase deficiency (SSADHD), which is an inborn GABA metabolism defect that causes intellectual disability, hypotonia, seizures, speech disturbance, and ataxia through the accumulation of γ-Hydroxybutyric acid (<a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a>). Vigabatrin helps lower GHB levels through GABA transaminase inhibition. However, this is in the brain only; it has no effect on peripheral GABA transaminase, so the GHB keeps building up and eventually reaches the brain.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Central_nervous_system">Central nervous system</h3></summary>
    
<p>Sleepiness (12.5%), headache (3.8%), dizziness (3.8%), nervousness (2.7%), depression (2.5%), memory disturbances (2.3%), diplopia (2.2%), aggression (2.0%), ataxia (1.9%), vertigo (1.9%), hyperactivity (1.8%), vision loss (1.6%) (See below), confusion (1.4%), insomnia (1.3%), impaired concentration (1.2%), personality issues (1.1%).<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-2"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Out of 299 children, 33 (11%) became hyperactive.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-3"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Some patients develop psychosis during the course of vigabatrin therapy,<span class="mw-ref" id="cite_ref-psyhosis_7-0"><a href="#cite_note-psyhosis-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> which is more common in adults than in children.<span class="mw-ref" id="cite_ref-pediatric_psychosis_8-0"><a href="#cite_note-pediatric_psychosis-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> This can happen even in patients with no prior history of psychosis.<span class="mw-ref" id="cite_ref-never_before_9-0"><a href="#cite_note-never_before-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Other rare CNS side effects include anxiety, emotional lability, irritability, tremor, abnormal gait, and speech disorder.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-4"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Gastrointestinal">Gastrointestinal</h3></summary>
    
<p>Abdominal pain (1.6%), constipation (1.4%), vomiting (1.4%), and nausea (1.4%). Dyspepsia and increased appetite occurred in less than 1% of subjects in clinical trials.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-5"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Body_as_a_whole">Body as a whole</h3></summary>
    
<p>Fatigue (9.2%), weight gain (5.0%), asthenia (1.1%).<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-6"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Teratogenicity">Teratogenicity</h3></summary>
    
<p>A teratology study conducted in rabbits found that a dose of 150<span>&nbsp;</span>mg/kg/day caused cleft palate in 2% of pups and a dose of 200<span>&nbsp;</span>mg/kg/day caused it in 9%.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-7"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> This may be due to a decrease in <a href="Methionine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methionine" title="Methionine">methionine</a> levels, according to a study published in March 2001.<span class="mw-ref" id="cite_ref-teratogenicity_possible_mechanism_10-0"><a href="#cite_note-teratogenicity_possible_mechanism-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In 2005, a study conducted at the University of Catania was published stating that rats whose mothers had consumed 250–1000<span>&nbsp;</span>mg/kg/day had poorer performance in the water maze and <span class="new">open-field tasks</span>, rats in the 750-mg group were underweight at birth and did not catch up to the control group, and rats in the 1000<span>&nbsp;</span>mg group did not survive pregnancy.<span class="mw-ref" id="cite_ref-teratology_rat_11-0"><a href="#cite_note-teratology_rat-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>There is no controlled teratology data in humans to date.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Sensory">Sensory</h3></summary>
    
<p>In 2003, vigabatrin was shown by Frisén and Malmgren to cause irreversible diffuse atrophy of the retinal nerve fiber layer in a retrospective study of 25 patients.<span class="mw-ref" id="cite_ref-vigabatrinretina_12-0"><a href="#cite_note-vigabatrinretina-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> This has the most effect on the outer area (as opposed to the macular, or central area) of the retina.<span class="mw-ref" id="cite_ref-retinalatrophy_13-0"><a href="#cite_note-retinalatrophy-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span>
Visual field defects had been reported as early as 1997 by Tom Eke and others, in the UK. Some authors, including Comaish et al. believe that visual field loss and electrophysiological changes may be demonstrable in up to 50% of Vigabatrin users.</p>

<p>The retinal toxicity of vigabatrin can be attributed to a <a href="Taurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Taurine" title="Taurine">taurine</a> depletion.<span class="mw-ref" id="cite_ref-PMID_22476345_14-0"><a href="#cite_note-PMID_22476345-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Due to safety issues, the Vigabatrin REMS Program is required by the FDA to ensure informed decisions before initiating and to ensure appropriate use of this drug.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>A study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of <a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">carbamazepine</a>.<span class="mw-ref" id="cite_ref-vigabatrin_carbamazepine_16-0"><a href="#cite_note-vigabatrin_carbamazepine-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a> lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy.<span class="mw-ref" id="cite_ref-phenytoin_17-0"><a href="#cite_note-phenytoin-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Five years later, the same two scientists reported a fall in concentration of phenytoin of 23% within five weeks in a paper describing their failed attempt at elucidating the mechanism behind this interaction.<span class="mw-ref" id="cite_ref-phenytoin2_18-0"><a href="#cite_note-phenytoin2-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    <p>
Vigabatrin is an irreversible mechanism-based inhibitor of gamma-aminobutyric acid aminotransferase (GABA-AT), the enzyme responsible for the catabolism of <a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/GABA" title="GABA" class="mw-redirect">GABA</a>. Inhibition of GABA-AT results in increased levels of <a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/GABA" title="GABA" class="mw-redirect">GABA</a> in the brain.<span class="mw-ref" id="cite_ref-what_is_vigabatrin_2-8"><a href="#cite_note-what_is_vigabatrin-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Vigabatrin is a racemic compound, and its [S]-enantiomer is pharmacologically active.<span class="mw-ref" id="cite_ref-senantiomer_20-0"><a href="#cite_note-senantiomer-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><sup>,</sup><span class="mw-ref" id="cite_ref-Gram_et_al_1989_21-0"><a href="#cite_note-Gram_et_al_1989-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> </p><div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/page1-220px-Vigabatrin_Chimera.pdf.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/page1-220px-Vigabatrin_Chimera.pdf.jpg" data-file-width="1275" data-file-height="1650" data-file-type="office" height="285" width="220"><div class="thumbcaption" style="text-align: left">Crystal Structure (pdb:1OHW) showing vigabatrin binding to specific residues in the active site of GABA-AT, based on experiments by Storici et al.<span class="mw-ref" id="cite_ref-Storici_et_al_2003_22-0"><a href="#cite_note-Storici_et_al_2003-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></div></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>With most drugs, elimination half-life is a useful predictor of dosing schedules and the time needed to reach steady state concentrations. In the case of vigabatrin, however, it has been found that the half-life of biologic activity is far longer than the elimination half-life.<span class="mw-ref" id="cite_ref-bioactivehalflife_23-0"><a href="#cite_note-bioactivehalflife-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>For vigabatrin, there is no range of target concentrations because researchers found no difference between the serum concentration levels of responders and those of non-responders.<span class="mw-ref" id="cite_ref-karolinska_no_correlation_24-0"><a href="#cite_note-karolinska_no_correlation-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Instead, the duration of action is believed to be more a function of the GABA-T resynthesis rate; levels of GABA-T do not usually return to their normal state until six days after stopping the medication.<span class="mw-ref" id="cite_ref-Gram_et_al_1989_21-1"><a href="#cite_note-Gram_et_al_1989-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Vigabatrin was developed in the 1980s with the specific goal of increasing GABA concentrations in the brain in order to stop an epileptic seizure. To do this, the drug was designed to irreversibly inhibit the GABA transaminase, which degrades the GABA substrate. Although the drug was approved for treatment in the United Kingdom in 1989, the authorized use of Vigabatrin by US Food and Drug Administration was delayed twice in the United States before 2009. It was delayed in 1983 because animal trials produced intramyelinic edema, however, the effects were not apparent in human trials so the drug design continued. In 1997, the trials were temporarily suspended because it was linked to peripheral visual field defects in humans.<span class="mw-ref" id="cite_ref-drug_design_25-0"><a href="#cite_note-drug_design-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_Names">Brand Names</h3></summary>
    
<p>Vigabatrin is sold as Sabril in Canada,<span class="mw-ref" id="cite_ref-Canada_26-0"><a href="#cite_note-Canada-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Mexico,<span class="mw-ref" id="cite_ref-mexicanuses_3-2"><a href="#cite_note-mexicanuses-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span>
and the United Kingdom.<span class="mw-ref" id="cite_ref-UnitedKingdom_27-0"><a href="#cite_note-UnitedKingdom-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> The brand name in Denmark is Sabrilex. Sabril was approved in the United States on August 21, 2009 and is currently marketed in the U.S. by Lundbeck Inc., which acquired Ovation Pharmaceuticals, the U.S. sponsor in March 2009.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_equivalents">Generic equivalents</h3></summary>
    
<p>On January 16, 2019, the FDA approved the first generic version of Sabril (vigabatrin) in the United States.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm" class="external text external">"Press Announcements - FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy"</a>. <i>www.fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">21 January</span> 2019</span>.</cite></span></li><li id="cite_note-what_is_vigabatrin-2"> <span id="mw-reference-text-cite_note-what_is_vigabatrin-2" class="mw-reference-text">Long, Phillip W. <a href="javascript:if(confirm('http://www.mentalhealth.com/drug/p30-s07.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mentalhealth.com/drug/p30-s07.html'" tppabs="http://www.mentalhealth.com/drug/p30-s07.html" class="external text external">"Vigabatrin."</a> <a href="javascript:if(confirm('https://web.archive.org/web/20060423082047/http://www.mentalhealth.com/drug/p30-s07.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060423082047/http://www.mentalhealth.com/drug/p30-s07.html'" tppabs="https://web.archive.org/web/20060423082047/http://www.mentalhealth.com/drug/p30-s07.html" class="external text external">Archived</a><span> April 23, 2006, at the </span>Wayback Machine Internet Mental Health. 1995–2003.</span></li><li id="cite_note-mexicanuses-3"> <span id="mw-reference-text-cite_note-mexicanuses-3" class="mw-reference-text"><a href="javascript:if(confirm('http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm'" tppabs="http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm" class="external text external">DEF Mexico: Sabril</a> <a href="javascript:if(confirm('https://web.archive.org/web/20050914050706/http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20050914050706/http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm'" tppabs="https://web.archive.org/web/20050914050706/http://www.facmed.unam.mx/bmnd/plm/mex/productos/10130.htm" class="external text external">Archived</a><span> September 14, 2005, at the </span>Wayback Machine <i>Diccionario de Especialdades Farmaceuticas.</i> Edicion 49, 2003.</span></li><li id="cite_note-lennoxgastaut-4"> <span id="mw-reference-text-cite_note-lennoxgastaut-4" class="mw-reference-text"><cite id="CITEREFFeuchtBrantner-Inthaler1994" class="citation journal cs1">Feucht M, Brantner-Inthaler S (1994). "Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study". <i>Epilepsia</i>. <b>35</b> (5): 993–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1528-1157.1994.tb02544.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1528-1157.1994.tb02544.x'" tppabs="https://doi.org/10.1111%2Fj.1528-1157.1994.tb02544.x" class="external text external">10.1111/j.1528-1157.1994.tb02544.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7925171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7925171'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7925171" class="external text external">7925171</a>.</cite></span></li><li id="cite_note-vigabatrinpanic-5"> <span id="mw-reference-text-cite_note-vigabatrinpanic-5" class="mw-reference-text"><cite id="CITEREFZwanzgerBaghaiSchueleStrohle2001" class="citation journal cs1">Zwanzger P, Baghai TC, Schuele C, Strohle A, Padberg F, Kathmann N, Schwarz M, Moller HJ, Rupprecht R (2001). <a href="javascript:if(confirm('https://doi.org/10.1016/S0893-133X(01)00266-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/S0893-133X(01)00266-4'" tppabs="https://doi.org/10.1016/S0893-133X(01)00266-4" class="external text external">"Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers"</a>. <i>Neuropsychopharmacology</i>. <b>25</b> (5): 699–703. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2FS0893-133X%2801%2900266-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0893-133X%2801%2900266-4'" tppabs="https://doi.org/10.1016%2FS0893-133X%2801%2900266-4" class="external text external">10.1016/S0893-133X(01)00266-4</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11682253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11682253'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11682253" class="external text external">11682253</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFPearlRobbins,_EmilyCapp,_Philip_KGasior,_Maciej2004" class="citation web cs1">Pearl, Phillip L; Robbins, Emily; Capp, Philip K; Gasior, Maciej; Gibson, K Michael (May 5, 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ssadh  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ssadh'" tppabs="https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ssadh" class="external text external">"Succinic Semialdehyde Dehydrogenase Deficiency"</a>. <i>GeneReviews</i>. Seattle, Washington: University of Washington<span class="reference-accessdate">. Retrieved <span class="nowrap">September 6,</span> 2010</span>.</cite></span></li><li id="cite_note-psyhosis-7"> <span id="mw-reference-text-cite_note-psyhosis-7" class="mw-reference-text"><cite id="CITEREFSanderHart1990" class="citation journal cs1">Sander JW, Hart YM (1990). "Vigabatrin and behaviour disturbance". <i>Lancet</i>. <b>335</b> (8680): 57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0140-6736%2890%2990190-G  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0140-6736%2890%2990190-G'" tppabs="https://doi.org/10.1016%2F0140-6736%2890%2990190-G" class="external text external">10.1016/0140-6736(90)90190-G</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1967367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1967367'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1967367" class="external text external">1967367</a>.</cite></span></li><li id="cite_note-pediatric_psychosis-8"> <span id="mw-reference-text-cite_note-pediatric_psychosis-8" class="mw-reference-text"><cite id="CITEREFChiarettiCastorinaTortoroloPiastra1994" class="citation journal cs1">Chiaretti A, Castorina M, Tortorolo L, Piastra M, Polidori G (1994). "[Acute psychosis and vigabatrin in childhood]". <i>La Pediatria Medica e Chirurgica<span>&nbsp;</span>: Medical and Surgical Pediatrics</i> (in Italian). <b>16</b> (5): 489–90. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7885961  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7885961'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7885961" class="external text external">7885961</a>.</cite></span></li><li id="cite_note-never_before-9"> <span id="mw-reference-text-cite_note-never_before-9" class="mw-reference-text"><cite id="CITEREFSanderHartTrimbleShorvon1991" class="citation journal cs1">Sander JW, Hart YM, Trimble MR, Shorvon SD (1991). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544" class="external text external">"Vigabatrin and psychosis"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>54</b> (5): 435–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fjnnp.54.5.435  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fjnnp.54.5.435'" tppabs="https://doi.org/10.1136%2Fjnnp.54.5.435" class="external text external">10.1136/jnnp.54.5.435</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC488544" class="external text external">488544</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1865207  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1865207'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1865207" class="external text external">1865207</a>.</cite></span></li><li id="cite_note-teratogenicity_possible_mechanism-10"> <span id="mw-reference-text-cite_note-teratogenicity_possible_mechanism-10" class="mw-reference-text"><cite id="CITEREFAbdulrazzaqPadmanabhanBastakiIbrahim2001" class="citation journal cs1">Abdulrazzaq YM, Padmanabhan R, Bastaki SM, Ibrahim A, Bener A (2001). "Placental transfer of vigabatrin (gamma-vinyl GABA) and its effect on concentration of amino acids in the embryo of TO mice". <i>Teratology</i>. <b>63</b> (3): 127–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Ftera.1023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Ftera.1023'" tppabs="https://doi.org/10.1002%2Ftera.1023" class="external text external">10.1002/tera.1023</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11283969  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11283969'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11283969" class="external text external">11283969</a>.</cite></span></li><li id="cite_note-teratology_rat-11"> <span id="mw-reference-text-cite_note-teratology_rat-11" class="mw-reference-text"><cite id="CITEREFLombardoLeanzaMeliLombardo2005" class="citation journal cs1">Lombardo SA, Leanza G, Meli C, Lombardo ME, Mazzone L, Vincenti I, Cioni M (2005). <a href="javascript:if(confirm('https://art.torvergata.it/bitstream/2108/194069/1/lombardo2005.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://art.torvergata.it/bitstream/2108/194069/1/lombardo2005.pdf'" tppabs="https://art.torvergata.it/bitstream/2108/194069/1/lombardo2005.pdf" class="external text external">"Maternal exposure to the antiepileptic drug vigabatrin affects postnatal development in the rat"</a> <span class="cs1-format">(PDF)</span>. <i>Neurological Sciences</i>. <b>26</b> (2): 89–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10072-005-0441-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10072-005-0441-6'" tppabs="https://doi.org/10.1007%2Fs10072-005-0441-6" class="external text external">10.1007/s10072-005-0441-6</a>. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/2108%2F194069  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/2108%2F194069'" tppabs="https://hdl.handle.net/2108%2F194069" class="external text external">2108/194069</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15995825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15995825'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15995825" class="external text external">15995825</a>.</cite></span></li><li id="cite_note-vigabatrinretina-12"> <span id="mw-reference-text-cite_note-vigabatrinretina-12" class="mw-reference-text"><cite id="CITEREFFrisénMalmgren2003" class="citation journal cs1">Frisén L, Malmgren K (2003). "Characterization of vigabatrin-associated optic atrophy". <i>Acta Ophthalmologica Scandinavica</i>. <b>81</b> (5): 466–73. doi:<a href="javascript:if(confirm('https://doi.org/10.1034%2Fj.1600-0420.2003.00125.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1034%2Fj.1600-0420.2003.00125.x'" tppabs="https://doi.org/10.1034%2Fj.1600-0420.2003.00125.x" class="external text external">10.1034/j.1600-0420.2003.00125.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14510793  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14510793'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14510793" class="external text external">14510793</a>.</cite></span></li><li id="cite_note-retinalatrophy-13"> <span id="mw-reference-text-cite_note-retinalatrophy-13" class="mw-reference-text"><cite id="CITEREFBuncicWestallPantonMunn2004" class="citation journal cs1">Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ (2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364" class="external text external">"Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children"</a>. <i>Ophthalmology</i>. <b>111</b> (10): 1935–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ophtha.2004.03.036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ophtha.2004.03.036'" tppabs="https://doi.org/10.1016%2Fj.ophtha.2004.03.036" class="external text external">10.1016/j.ophtha.2004.03.036</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880364" class="external text external">3880364</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15465561  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15465561'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15465561" class="external text external">15465561</a>.</cite></span></li><li id="cite_note-PMID_22476345-14"> <span id="mw-reference-text-cite_note-PMID_22476345-14" class="mw-reference-text"><cite id="CITEREFGaucher_DArnault_EHusson_Z2012" class="citation journal cs1">Gaucher D; Arnault E; Husson Z;  et al. (November 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058" class="external text external">"Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells"</a>. <i>Amino Acids</i>. <b>43</b> (5): 1979–1993. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00726-012-1273-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00726-012-1273-3'" tppabs="https://doi.org/10.1007%2Fs00726-012-1273-3" class="external text external">10.1007/s00726-012-1273-3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472058" class="external text external">3472058</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22476345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22476345'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22476345" class="external text external">22476345</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dev.sabril.net/prescribing-sabril  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dev.sabril.net/prescribing-sabril'" tppabs="https://dev.sabril.net/prescribing-sabril" class="external text external">"SABRIL® (vigabatrin) tablets, for oral use SABRIL® (vigabatrin) powder for oral..."</a> <i>Sabril.net</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-05-31</span></span>.</cite></span></li><li id="cite_note-vigabatrin_carbamazepine-16"> <span id="mw-reference-text-cite_note-vigabatrin_carbamazepine-16" class="mw-reference-text"><cite id="CITEREFSanchez-AlcarazQuintana_MBLopez_ERodriguez_I2002" class="citation journal cs1">Sanchez-Alcaraz, Agustín; Quintana MB; Lopez E; Rodriguez I; Llopis P (2002). "Effect of vigabatrin on the pharmacokinetics of carbamazepine". <i>Journal of Clinical Pharmacy and Therapeutics</i>. <b>27</b> (6): 427–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1365-2710.2002.00441.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1365-2710.2002.00441.x'" tppabs="https://doi.org/10.1046%2Fj.1365-2710.2002.00441.x" class="external text external">10.1046/j.1365-2710.2002.00441.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12472982  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12472982'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12472982" class="external text external">12472982</a>.</cite></span></li><li id="cite_note-phenytoin-17"> <span id="mw-reference-text-cite_note-phenytoin-17" class="mw-reference-text"><cite id="CITEREFRimmerRichens1984" class="citation journal cs1">Rimmer EM, Richens A (1984). "Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy". <i>Lancet</i>. <b>1</b> (8370): 189–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2884%2992112-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2884%2992112-3'" tppabs="https://doi.org/10.1016%2FS0140-6736%2884%2992112-3" class="external text external">10.1016/S0140-6736(84)92112-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6141335  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6141335'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6141335" class="external text external">6141335</a>.</cite></span></li><li id="cite_note-phenytoin2-18"> <span id="mw-reference-text-cite_note-phenytoin2-18" class="mw-reference-text"><cite id="CITEREFRimmerRichens1989" class="citation journal cs1">Rimmer EM, Richens A (1989). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676" class="external text external">"Interaction between vigabatrin and phenytoin"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>27</b> (Suppl 1): 27S–33S. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1989.tb03458.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1989.tb03458.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1989.tb03458.x" class="external text external">10.1111/j.1365-2125.1989.tb03458.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379676" class="external text external">1379676</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2757906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2757906'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2757906" class="external text external">2757906</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFRogawskiLöscher2004" class="citation journal cs1">Rogawski MA, Löscher W (2004). <a href="javascript:if(confirm('https://zenodo.org/record/1233562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1233562'" tppabs="https://zenodo.org/record/1233562" class="external text external">"The neurobiology of antiepileptic drugs"</a>. <i>Nat Rev Neurosci</i>. <b>5</b> (7): 553–564. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrn1430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrn1430'" tppabs="https://doi.org/10.1038%2Fnrn1430" class="external text external">10.1038/nrn1430</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15208697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15208697'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15208697" class="external text external">15208697</a>.</cite></span></li><li id="cite_note-senantiomer-20"> <span id="mw-reference-text-cite_note-senantiomer-20" class="mw-reference-text"><cite id="CITEREFSheeanSchramm_TAnderson_DSEadie_MJ.1992" class="citation journal cs1">Sheean, G.; Schramm T; Anderson DS; Eadie MJ. (1992). "Vigabatrin--plasma enantiomer concentrations and clinical effects". <i>Clinical and Experimental Neurology</i>. <b>29</b>: 107–16. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1343855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1343855'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1343855" class="external text external">1343855</a>.</cite></span></li><li id="cite_note-Gram_et_al_1989-21"> <span id="mw-reference-text-cite_note-Gram_et_al_1989-21" class="mw-reference-text"><cite id="CITEREFGramLarssonJohnsenSchousboe1989" class="citation journal cs1">Gram L, Larsson OM, Johnsen A, Schousboe A (1989). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673" class="external text external">"Experimental studies of the influence of vigabatrin on the GABA system"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>27</b> (Suppl 1): 13S–17S. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.1989.tb03455.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.1989.tb03455.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.1989.tb03455.x" class="external text external">10.1111/j.1365-2125.1989.tb03455.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379673" class="external text external">1379673</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2757904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2757904'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2757904" class="external text external">2757904</a>.</cite></span></li><li id="cite_note-Storici_et_al_2003-22"> <span id="mw-reference-text-cite_note-Storici_et_al_2003-22" class="mw-reference-text"><cite id="CITEREFStorici_PaolaDe_Biase_DBossa_FBruno_S2003" class="citation journal cs1">Storici Paola; De Biase D; Bossa F; Bruno S; Mozzarelli A; Peneff C; Silverman R; Schirmer T. (2003). <a href="javascript:if(confirm('https://doi.org/10.1074/jbc.M305884200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1074/jbc.M305884200'" tppabs="https://doi.org/10.1074/jbc.M305884200" class="external text external">"Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5'-Phosphate, and <span>[</span>2Fe-2S<span>]</span> Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin"</a>. <i>The Journal of Biological Chemistry</i>. <b>279</b> (1): 363–73. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1074%2Fjbc.M305884200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1074%2Fjbc.M305884200'" tppabs="https://doi.org/10.1074%2Fjbc.M305884200" class="external text external">10.1074/jbc.M305884200</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14534310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14534310'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14534310" class="external text external">14534310</a>.</cite></span></li><li id="cite_note-bioactivehalflife-23"> <span id="mw-reference-text-cite_note-bioactivehalflife-23" class="mw-reference-text"><cite id="CITEREFBrowne_TR1998" class="citation journal cs1">Browne TR (1998). "Pharmacokinetics of antiepileptic drugs". <i>Neurology</i>. <b>51</b> (5 suppl 4): S2–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2Fwnl.51.5_suppl_4.s2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2Fwnl.51.5_suppl_4.s2'" tppabs="https://doi.org/10.1212%2Fwnl.51.5_suppl_4.s2" class="external text external">10.1212/wnl.51.5_suppl_4.s2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9818917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9818917'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9818917" class="external text external">9818917</a>.</cite></span></li><li id="cite_note-karolinska_no_correlation-24"> <span id="mw-reference-text-cite_note-karolinska_no_correlation-24" class="mw-reference-text"><cite id="CITEREFLindbergerLuhrJohannessenLarsson2003" class="citation journal cs1">Lindberger M, Luhr O, Johannessen SI, Larsson S, Tomson T (2003). "Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study". <i>Therapeutic Drug Monitoring</i>. <b>25</b> (4): 457–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007691-200308000-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007691-200308000-00007'" tppabs="https://doi.org/10.1097%2F00007691-200308000-00007" class="external text external">10.1097/00007691-200308000-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12883229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12883229'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12883229" class="external text external">12883229</a>.</cite></span></li><li id="cite_note-drug_design-25"> <span id="mw-reference-text-cite_note-drug_design-25" class="mw-reference-text"><cite id="CITEREFBen-Menachem_E.2011" class="citation journal cs1">Ben-Menachem E. (2011). "Mechanism of Action of vigabatrin: correcting misperceptions". <i>Acta Neurologica Scandinavica</i>. <b>124</b> (192): 5–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0404.2011.01596.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0404.2011.01596.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0404.2011.01596.x" class="external text external">10.1111/j.1600-0404.2011.01596.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22061176  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22061176'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22061176" class="external text external">22061176</a>.</cite></span></li><li id="cite_note-Canada-26"> <span id="mw-reference-text-cite_note-Canada-26" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugs.com/cons/Vigabatrin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cons/Vigabatrin.html'" tppabs="https://www.drugs.com/cons/Vigabatrin.html" class="external text external">drugs.com Vigabatrin Drug Information</a></span></li><li id="cite_note-UnitedKingdom-27"> <span id="mw-reference-text-cite_note-UnitedKingdom-27" class="mw-reference-text"><a href="javascript:if(confirm('http://webarchive.nationalarchives.gov.uk/20081112143554/http://www.nmhct.nhs.uk/pharmacy/epi5.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://webarchive.nationalarchives.gov.uk/20081112143554/http://www.nmhct.nhs.uk/pharmacy/epi5.htm'" tppabs="http://webarchive.nationalarchives.gov.uk/20081112143554/http://www.nmhct.nhs.uk/pharmacy/epi5.htm" class="external text external">Treatments for Epilepsy - Vigabatrin</a> Norfolk and Waveney Mental Health Partnership NHS Trust</span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629569.htm" class="external text external">"FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy"</a>. <i>U.S. Food and Drug Administration</i>. 2019-09-11.</cite></span></li></ol></div>

<div role="navigation" class="navbox" aria-labelledby="Anticonvulsants_(N03)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Anticonvulsants_(N03)" style="font-size:114%;margin:0 4em">Anticonvulsants (N03)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">GABAergics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">GABA<sub>A</sub>R PAMs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a>:</b> Barbexaclone</li>
<li><a href="Metharbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Metharbital" title="Metharbital">Metharbital</a></li>
<li><a href="Methylphenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenobarbital" title="Methylphenobarbital">Methylphenobarbital</a></li>
<li><a href="Pentobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentobarbital" title="Pentobarbital">Pentobarbital</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a><sup>#</sup></li>
<li><a href="Primidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Primidone" title="Primidone">Primidone</a>; <b>Carbamates</b>: Cenobamate</li>
<li><a href="Felbamate.htm" tppabs="https://ptable.com/wiki/compounds/A/Felbamate" title="Felbamate">Felbamate</a>; <b>Benzodiazepines</b>: <a href="Clobazam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Lorazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li><a href="Midazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Midazolam" title="Midazolam">Midazolam</a></li>
<li>Nimetazepam</li>
<li><a href="Nitrazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrazepam" title="Nitrazepam">Nitrazepam</a></li>
<li><a href="Temazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Temazepam" title="Temazepam">Temazepam</a>; <b>Others:</b> Bromide (<a href="Potassium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium_bromide" title="Potassium bromide">potassium bromide</a>, <a href="Sodium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_bromide" title="Sodium bromide">sodium bromide</a>)</li>
<li>Imepitoin</li>
<li><a href="Paraldehyde.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraldehyde" title="Paraldehyde">Paraldehyde</a></li>
<li>Stiripentol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">GABA-T inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Fatty acids (and related):</b> Valproate</li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li>Valproate pivoxil</li>
<li><a href="Vigabatrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vigabatrin" title="Vigabatrin">Vigabatrin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>GABAR agonists</b>: <a href="Progabide.htm" tppabs="https://ptable.com/wiki/compounds/A/Progabide" title="Progabide">Progabide</a>; <b>GAT-1 inhibitors:</b> <a href="Tiagabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiagabine" title="Tiagabine">Tiagabine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Channel<br>modulators</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Sodium blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><a href="Hydantoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydantoin" title="Hydantoin">Hydantoins</a>:</b> <a href="Ethotoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li><a href="Mephenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a><sup>#</sup>; <b>Ureides:</b> <span class="new">Acetylpheneturide</span></li>
<li>Chlorphenacemide</li>
<li><a href="Phenacemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenacemide" title="Phenacemide">Phenacemide</a><sup>‡</sup></li>
<li>Pheneturide; <b>Fatty acids:</b> Valproate</li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li>Valproate pivoxil; <b>Carboxamides:</b> Brivaracetam</li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a><sup>#</sup></li>
<li>Eslicarbazepine acetate</li>
<li><a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a>; <b>Others:</b> Lacosamide</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li>Rufinamide</li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Calcium blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Oxazolidinediones:</b> Ethadione</li>
<li><a href="Paramethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Trimethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethadione" title="Trimethadione">Trimethadione</a>; <b><a href="Succinimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Succinimide" title="Succinimide">Succinimides</a></b>: <a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a><sup>#</sup></li>
<li><a href="Mesuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li><a href="Phensuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phensuximide" title="Phensuximide">Phensuximide</a>; <b>Gabapentinoids:</b> <a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a>; <b>Others:</b> Imepitoin</li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Potassium openers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Retigabine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">CA inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Sulfonamides:</b> <a href="Acetazolamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetazolamide" title="Acetazolamide">Acetazolamide</a></li>
<li><a href="Ethoxzolamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethoxzolamide" title="Ethoxzolamide">Ethoxzolamide</a></li>
<li>Sultiame</li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Albutoin</li>
<li>Beclamide</li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><a href="Etiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Etiracetam" title="Etiracetam">Etiracetam</a></li>
<li><a href="Levetiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li>Perampanel</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="GABA_metabolism_and_transport_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GABA_metabolism_and_transport_modulators" style="font-size:114%;margin:0 4em"><abbr>GABA</abbr> metabolism and transport modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Transporter</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;text-align:center;"><abbr>GAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Inhibitors:</i> <span class="new">4-Aminovaleric acid</span></li>
<li>β-Alanine</li>
<li>Arecaidine</li>
<li>CI-966</li>
<li><span class="new">DABA</span></li>
<li>Deramciclane (EGIS-3886, EGYT-3886)</li>
<li><span class="new">EF-1502</span></li>
<li><a href="Gabaculine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabaculine" title="Gabaculine">Gabaculine</a></li>
<li>Guvacine</li>
<li><a href="Ibotenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibotenic_acid" title="Ibotenic acid">Ibotenic acid</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a></li>
<li><a href="Nipecotic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Nipecotic_acid" title="Nipecotic acid">Nipecotic acid</a></li>
<li><span class="new">NNC 05-2090</span></li>
<li>NO-711</li>
<li><a href="Riluzole.htm" tppabs="https://ptable.com/wiki/compounds/A/Riluzole" title="Riluzole">Riluzole</a></li>
<li>SKF-89976A</li>
<li><span class="new">SNAP-5114</span></li>
<li><span class="new">TACA</span></li>
<li><a href="Tiagabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiagabine" title="Tiagabine">Tiagabine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;text-align:center;"><abbr>VIAAT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Inhibitors:</i> β-Alanine</li>
<li>Bafilomycin A1</li>
<li><span class="new">Chicago sky blue 6B</span></li>
<li>Evans blue</li>
<li><a href="Gamma-Aminobutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/GABA" title="GABA" class="mw-redirect">GABA</a></li>
<li><a href="Glycine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycine" title="Glycine">Glycine</a></li>
<li>N-Butyric acid</li>
<li><a href="Nigericin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nigericin" title="Nigericin">Nigericin</a></li>
<li><a href="Nipecotic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Nipecotic_acid" title="Nipecotic acid">Nipecotic acid</a></li>
<li><a href="Valinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Valinomycin" title="Valinomycin">Valinomycin</a></li>
<li><a href="Vigabatrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vigabatrin" title="Vigabatrin">Vigabatrin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Enzyme</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;text-align:center;"><abbr>GAD</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Inhibitors:</i> 3-Mercaptopropionic acid</li>
<li><a href="Aminooxyacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminooxyacetic_acid" title="Aminooxyacetic acid">AAOA</a></li>
<li><a href="Allylglycine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Allylglycine" title="L-Allylglycine" class="mw-redirect"><span style="font-size:90%;">L</span>-Allylglycine</a></li>
<li><a href="Semicarbazide.htm" tppabs="https://ptable.com/wiki/compounds/A/Semicarbazide" title="Semicarbazide">Semicarbazide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;text-align:center;"><abbr>GABA-T</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Inhibitors:</i> <span class="new">3-Hydrazinopropionic acid</span></li>
<li><span class="new">γ-Acetylenic-GABA</span></li>
<li><a href="Aminooxyacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminooxyacetic_acid" title="Aminooxyacetic acid">AOAA</a></li>
<li><a href="Ethanolamine-O-sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanolamine-O-sulfate" title="Ethanolamine-O-sulfate">EOS</a></li>
<li><a href="Gabaculine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabaculine" title="Gabaculine">Gabaculine</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a></li>
<li><a href="Cycloserine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Cycloserine" title="L-Cycloserine" class="mw-redirect"><small>L</small>-Cycloserine</a></li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>PEH</li>
<li><a href="Rosmarinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosmarinic_acid" title="Rosmarinic acid">Rosmarinic acid</a> (lemon balm)</li>
<li><a href="Sodium_valproate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_valproate" title="Sodium valproate" class="mw-redirect">Sodium valproate</a></li>
<li>Valnoctamide</li>
<li>Valproate pivoxil</li>
<li><a href="Valproate_semisodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproate_semisodium" title="Valproate semisodium" class="mw-redirect">Valproate semisodium (divalproex sodium)</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Vigabatrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vigabatrin" title="Vigabatrin">Vigabatrin</a></li></ul>

<ul><li><i>Activators:</i> <span class="new">3-Methyl-GABA</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators </i></dd>
<dd><i>GABA receptor modulators </i></dd>
<dd><i>GABA<sub>A</sub> receptor positive modulators </i></dd>
<dd><i>Glutamate metabolism/transport modulators </i></dd></dl>
</div></td></tr></tbody></table></div>






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-01" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Vigabatrin&oldid=970667815  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Vigabatrin&oldid=970667815'" tppabs="https://en.wikipedia.org/wiki/?title=Vigabatrin&oldid=970667815">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>